DUBLIN--(BUSINESS WIRE)--The "Newborn Screening Market By Product Type, By Test Type, By Technology, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.
The global newborn screening market valued at $ 1,055.24 million in 2021, and is projected to reach $ 2,038.47 million by 2031, registering a CAGR of 6.8% from 2022 to 2031.
Newborn screening test is the series of test performed during the first few days of your baby's life, usually by a hospital health care practitioner. A few drops of blood from a heel prick are placed on a special card, called a Guthrie card. this card, along with your baby's details, is mailed to a specialized state laboratory, which will test the blood sample for a variety of health disorders, including CF (cystic fibrosis).
Newborn screening in certain states requires two blood samples, one at birth and the other a few weeks later. Newborn screening is essential for detection and early diagnosis of certain genetic, endocrine, and metabolic disorders, and are also tested for hearing loss and critical congenital heart defects (CCHDs).
The major factors that drive the growth of the global newborn screening market include increasing government support for newborn screening and development in screening technology. In addition, high birth rate and increasing incidence of neonatal disease propel the market growth.
However, lack of improvement in healthcare infrastructure. Conversely, screening of genetic disorders and emerging market such as Brazil, China and India provide significant opportunities to key players in this market due to increase in birth rates and rise in disposable income.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the newborn screening market analysis from 2021 to 2031 to identify the prevailing Newborn Screening Market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the newborn screening market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global newborn screening market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
- Instrument
- Consumables
By Test Type
- Blood test
- Hearing screening test
- Heart screening
By Technology
- Tandem Mass Spectrometry (TMS)
- Molecular Assays
- Immunoassays and Enzymatic Assays
- Hearing Screen Technology
- Pulse Oximetry Screening Technology
- Others
By End User
- Hospitals
- Clinical laboratories
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- Italy
- Spain
- Rest of Europe
- France
- U.K.
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Ab Sciex LLC
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Covidien Plc
- Ge Healthcare
- PERKINELMER, INC.
- MASIMO CORPORATION
- Natus Medical Incorporated
- Trivitron Healthcare
- Waters Corporation
For more information about this report visit https://www.researchandmarkets.com/r/lvufn1
